...
首页> 外文期刊>Clinical EEG and neuroscience: official journal of the EEG and Clinical Neuroscience Society (ENCS) >Shared mechanisms of antidepressant and antiepileptic treatments: drugs and devices.
【24h】

Shared mechanisms of antidepressant and antiepileptic treatments: drugs and devices.

机译:抗抑郁和抗癫痫治疗的共同机制:药物和装置。

获取原文
获取原文并翻译 | 示例
           

摘要

Many treatments for the epilepsies and affective disorder share the properties of seizure suppression and mood stabilization. Moreover, affective disorders and the epilepsies appear to share partially similar pathogenic mechanisms. A component of the shared predisposition appears to arise from noradrenergic and serotonergic deficits. Increasing evidence supports the hypothesis that noradrenergic and/or serotonergic elevation is a mechanism of therapeutic benefit shared by most antidepressants and many antiepileptic medications. Medication induced alterations in GABAergic, glutamatergic, and CRH (corticotropin releasing hormone) containing neurons may also contribute to the shared therapeutic properties of antidepressant and antiepileptic medications.
机译:癫痫和情感障碍的许多治疗方法均具有抑制癫痫发作和稳定情绪的特性。此外,情感障碍和癫痫病似乎具有部分相似的致病机制。共有诱因的一部分似乎是由去甲肾上腺素能和血清素能缺乏引起的。越来越多的证据支持以下假设,即去甲肾上腺素能和/或血清素能升高是大多数抗抑郁药和许多抗癫痫药共有的一种治疗获益机制。药物引起的含有GABA能,谷氨酸能和CRH(促肾上腺皮质激素释放激素)的神经元发生改变也可能有助于抗抑郁药和抗癫痫药的共同治疗特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号